ATE204173T1 - Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren - Google Patents

Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren

Info

Publication number
ATE204173T1
ATE204173T1 AT94118300T AT94118300T ATE204173T1 AT E204173 T1 ATE204173 T1 AT E204173T1 AT 94118300 T AT94118300 T AT 94118300T AT 94118300 T AT94118300 T AT 94118300T AT E204173 T1 ATE204173 T1 AT E204173T1
Authority
AT
Austria
Prior art keywords
ribofuranosyl
carboxamide
triazole
arboviruses
ribavirin
Prior art date
Application number
AT94118300T
Other languages
English (en)
Inventor
Robert Angus Smith
Humberto Fernandes
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE204173(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Application granted granted Critical
Publication of ATE204173T1 publication Critical patent/ATE204173T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT94118300T 1984-10-29 1985-04-16 Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren ATE204173T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29

Publications (1)

Publication Number Publication Date
ATE204173T1 true ATE204173T1 (de) 2001-09-15

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94118300T ATE204173T1 (de) 1984-10-29 1985-04-16 Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren

Country Status (19)

Country Link
EP (3) EP0383361A3 (de)
JP (1) JPH0713019B2 (de)
KR (1) KR860003018A (de)
AT (1) ATE204173T1 (de)
AU (1) AU584333B2 (de)
BE (1) BE902199A (de)
CA (1) CA1261265A (de)
DD (1) DD261094A5 (de)
DE (3) DE10299005I2 (de)
ES (1) ES8704962A1 (de)
FR (1) FR2572286B1 (de)
GB (1) GB2166050B (de)
HK (1) HK1010985A1 (de)
LU (1) LU85854A1 (de)
NL (1) NL300083I1 (de)
NZ (1) NZ212510A (de)
PH (1) PH22534A (de)
PT (1) PT81387B (de)
ZA (1) ZA858237B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501925A (ja) * 1985-12-23 1988-08-04 フレツド　ハツチンソン　キヤンサ−　リサ−チ　センタ− レトロウイルスの複製、感染及び疾病誘発の制御
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
JP2002535371A (ja) * 1999-01-29 2002-10-22 アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド リバビリンによる免疫応答の調節
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
WO2015197518A1 (en) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of sofosbuvir and ribavirin
EA201692514A1 (ru) 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические композиции на основе софосбувира и рибавирина с модифицированным высвобождением
EA201692515A1 (ru) 2014-06-23 2017-05-31 Сановель Илач Санайи Ве Тиджарет А.Ш. Новая фармацевтическая композиция на основе софосбувира и рибавирина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles

Also Published As

Publication number Publication date
EP0383361A3 (de) 1993-06-16
FR2572286A1 (fr) 1986-05-02
KR860003018A (ko) 1986-05-19
GB2166050A (en) 1986-04-30
NZ212510A (en) 1989-04-26
EP0383361A2 (de) 1990-08-22
EP0181050A2 (de) 1986-05-14
GB8509689D0 (en) 1985-05-22
JPH0713019B2 (ja) 1995-02-15
BE902199A (fr) 1985-07-31
AU4180785A (en) 1986-05-08
PT81387B (pt) 1987-11-11
JPS61109723A (ja) 1986-05-28
DD261094A5 (de) 1988-10-19
DE181050T1 (de) 1986-12-18
LU85854A1 (fr) 1985-12-16
ZA858237B (en) 1988-02-24
NL300083I1 (nl) 2002-05-01
DE10299005I2 (de) 2004-07-01
ES548303A0 (es) 1987-04-16
PH22534A (en) 1988-10-17
CA1261265A (en) 1989-09-26
FR2572286B1 (fr) 1990-03-23
EP0643970A3 (de) 1997-07-09
DE10299005I1 (de) 2002-05-08
EP0181050A3 (de) 1987-10-21
HK1010985A1 (en) 1999-07-02
PT81387A (en) 1985-11-01
ES8704962A1 (es) 1987-04-16
EP0643970A2 (de) 1995-03-22
EP0643970B1 (de) 2001-08-16
DE3588232D1 (de) 2001-09-20
DE3588232T2 (de) 2002-06-13
GB2166050B (en) 1989-08-16
AU584333B2 (en) 1989-05-25

Similar Documents

Publication Publication Date Title
DE69508192T2 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DE69024672T2 (de) Sprays zur Behandlung von Infektionen des Tractus Respiratorius
ATE114113T1 (de) Verwendung von droloxifen bei der behandlung von knochenerkrankungen.
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
ATE204173T1 (de) Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren
ATE390130T1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
ATE79254T1 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
ATE320263T1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
DE69424415T2 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE69626276D1 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
DE3777709D1 (de) Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
DE69529070T2 (de) Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
ATE58476T1 (de) Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit.
ATE98612T1 (de) Verfahren zur behandlung von einer waesserigen loesung, die insbesondere salpetersaeure und flusssaeure enthaelt.
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.